APA Alıntı

Barochia, A. V., Cui, X., Natanson, C., & Eichacker, P. Q. (2010). Risk of death and the efficacy of eritoran tetrasodium (E5564): Design considerations for clinical trials of anti-inflammatory agents in sepsis(*).

Chicago Stili Alıntı

Barochia, Amisha V., Xizhong Cui, Charles Natanson, ve Peter Q. Eichacker. Risk of Death and the Efficacy of Eritoran Tetrasodium (E5564): Design Considerations for Clinical Trials of Anti-inflammatory Agents in Sepsis(*). 2010.

MLA Alıntı

Barochia, Amisha V., Xizhong Cui, Charles Natanson, ve Peter Q. Eichacker. Risk of Death and the Efficacy of Eritoran Tetrasodium (E5564): Design Considerations for Clinical Trials of Anti-inflammatory Agents in Sepsis(*). 2010.